Anti-Myosin Light Chain 2 Antibody

HUABIO

Anti-Myosin Light Chain 2 Antibody

7

Flow Cytometry, ImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

WB,IF-Cell,IHC-P,FC

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

MYL2

myosin light chain 2

CMH10, MFM12, MLC-2, MLC-2s/v, MLC-2v, MLC2, myosin regulatory light chain 2, ventricular/cardiac muscle isoform, RLC of myosin, S15D myosin regulatory light chain 2, T160D myosin regulatory light chain 2, cardiac myosin light chain 2, cardiac ventricular myosin light chain 2, myosin, light chain 2, regulatory, cardiac, slow, myosin, light polypeptide 2, regulatory, cardiac, slow, regulatory light chain of myosin, slow cardiac myosin regulatory light chain 2, ventricular myosin light chain 2

Rabbit

IgG

Myosin regulatory light chain 2, ventricular/cardiac muscle isoform

Encoded by the MYL2 gene, myosin regulatory light chain 2, ventricular/cardiac muscle isoform, also designated MLC-2 or MLC2v, is part of a hexameric complex of two heavy chains and four light chains predominantly expressed in adult cardiac ventricle muscle. Myosin regulatory light chain 2 binds calcium and has been shown to be a useful molecular marker for cardiac chamber specification. The co-expression of myosin regulatory light chain 7 (MYL7) and myosin regulatory light chain 2 in the outflow tract and atrioventricular canal, together with the single expression in the atrial (MYL7) and ventricular (MYL2) myocardium, permits the delineation of their boundaries. At the amino acid level there is 96% homology between the human and mouse myosin regulatory light chain sequences. Mutations in MYL2 are correlated with mid-left ventricular chamber type hypertrophic cardiomyopathy (MVC2) as well as familial hypertrophic cardiomyopathy type 10 (CMH10).

Human, Mouse, Rat

Human,Mouse,Rat

-20°C,2°C to 8°C

41116161